FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387451353> ?p ?o ?g. }

• W4387451353 endingPage "6417" @default.
• W4387451353 startingPage "6417" @default.
• W4387451353 abstract "Both chronic obstructive pulmonary disease and bronchiectasis are highly prevalent diseases. In both cases, inhaled corticosteroids (ICs) are associated with a decrease in exacerbations in patients with a high peripheral blood eosinophil count (BEC), but it is still not known what occurs in bronchiectasis-COPD overlap syndrome (BCOS). The present study aimed to assess the effect of ICs on various outcomes in patients with BCOS, according to BEC values. We undertook a post-hoc analysis of a cohort of 201 GOLD II-IV COPD patients with a long-term follow-up (median 74 [IQR: 40-106] months). All participants underwent computerized tomography and 115 (57.2%) had confirmed BCOS. A standardized clinical protocol was followed and two sputum samples were collected at each medical visit (every 3-6 months), whenever possible. During follow-up, there were 68 deaths (59.1%), and the mean rate of exacerbations and hospitalizations per year was 1.42 (1.2) and 0.57 (0.83), respectively. A total of 44.3% of the patients presented at least one pneumonic episode per year. The mean value of eosinophils was 402 (112) eosinophils/µL, with 27 (23.5%), 63 (54.8%), and 25 patients (21.7%) presenting, respectively, less than 100, 101-300, and more than 300 eosinophils/µL. A total of 84 patients (73.1%) took ICs. The higher the BEC, the higher the annual rate of exacerbations and hospitalizations. Patients with less than 100 eosinophils/µL presented more infectious events (incident exacerbations, pneumonic episodes, and chronic bronchial infection via pathogenic bacteria). Only those patients with eosinophilia (>300 eosinophils/µL) treated with ICs decreased the number (1.77 (1.2) vs. 1.08 (0.6), p < 0.001) and the severity (0.67 (0.8) vs. 0.35 (0.5), p = 0.011) of exacerbations, without any changes in the other infectious outcomes or mortality. In conclusion, ICs treatment in patients with BCOS with increased BEC decreased the number and severity of incident exacerbations without any negative influence on other infectious outcomes (incidence of pneumonia or chronic bronchial infection)." @default.
• W4387451353 created "2023-10-10" @default.
• W4387451353 creator A5000570089 @default.
• W4387451353 creator A5000713820 @default.
• W4387451353 creator A5011481509 @default.
• W4387451353 creator A5037568748 @default.
• W4387451353 creator A5040016284 @default.
• W4387451353 creator A5066150834 @default.
• W4387451353 creator A5080142031 @default.
• W4387451353 creator A5093027552 @default.
• W4387451353 date "2023-10-09" @default.
• W4387451353 modified "2023-10-17" @default.
• W4387451353 title "Bronchiectasis-COPD Overlap Syndrome: Role of Peripheral Eosinophil Count and Inhaled Corticosteroid Treatment" @default.
• W4387451353 cites W1568547719 @default.
• W4387451353 cites W2015327085 @default.
• W4387451353 cites W2068880214 @default.
• W4387451353 cites W2108357872 @default.
• W4387451353 cites W2117532925 @default.
• W4387451353 cites W2147876251 @default.
• W4387451353 cites W2599496392 @default.
• W4387451353 cites W2752498201 @default.
• W4387451353 cites W2767251192 @default.
• W4387451353 cites W2778460624 @default.
• W4387451353 cites W2884457464 @default.
• W4387451353 cites W2891610856 @default.
• W4387451353 cites W2955803684 @default.
• W4387451353 cites W2981116407 @default.
• W4387451353 cites W2999350597 @default.
• W4387451353 cites W3006560550 @default.
• W4387451353 cites W3011807353 @default.
• W4387451353 cites W3024403076 @default.
• W4387451353 cites W3041746492 @default.
• W4387451353 cites W3087385223 @default.
• W4387451353 cites W3108828640 @default.
• W4387451353 cites W3138519932 @default.
• W4387451353 cites W3139270749 @default.
• W4387451353 cites W3154391028 @default.
• W4387451353 cites W3183709375 @default.
• W4387451353 cites W3195634563 @default.
• W4387451353 cites W3201264210 @default.
• W4387451353 cites W3203687830 @default.
• W4387451353 cites W3212058117 @default.
• W4387451353 cites W3214785964 @default.
• W4387451353 cites W4200061614 @default.
• W4387451353 cites W4205681937 @default.
• W4387451353 cites W4206117452 @default.
• W4387451353 cites W4210790249 @default.
• W4387451353 cites W4213268409 @default.
• W4387451353 cites W4213282797 @default.
• W4387451353 cites W4214923467 @default.
• W4387451353 cites W4223924695 @default.
• W4387451353 cites W4224937262 @default.
• W4387451353 cites W4226156373 @default.
• W4387451353 cites W4247938945 @default.
• W4387451353 cites W4252208865 @default.
• W4387451353 cites W4280589369 @default.
• W4387451353 cites W4281688405 @default.
• W4387451353 cites W4295959883 @default.
• W4387451353 cites W4306911778 @default.
• W4387451353 cites W4307956131 @default.
• W4387451353 cites W4322719510 @default.
• W4387451353 cites W4366751280 @default.
• W4387451353 cites W4377164038 @default.
• W4387451353 cites W4381033620 @default.
• W4387451353 cites W4386461633 @default.
• W4387451353 doi "https://doi.org/10.3390/jcm12196417" @default.
• W4387451353 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37835060" @default.
• W4387451353 hasPublicationYear "2023" @default.
• W4387451353 type Work @default.
• W4387451353 citedByCount "0" @default.
• W4387451353 crossrefType "journal-article" @default.
• W4387451353 hasAuthorship W4387451353A5000570089 @default.
• W4387451353 hasAuthorship W4387451353A5000713820 @default.
• W4387451353 hasAuthorship W4387451353A5011481509 @default.
• W4387451353 hasAuthorship W4387451353A5037568748 @default.
• W4387451353 hasAuthorship W4387451353A5040016284 @default.
• W4387451353 hasAuthorship W4387451353A5066150834 @default.
• W4387451353 hasAuthorship W4387451353A5080142031 @default.
• W4387451353 hasAuthorship W4387451353A5093027552 @default.
• W4387451353 hasBestOaLocation W43874513531 @default.
• W4387451353 hasConcept C126322002 @default.
• W4387451353 hasConcept C142724271 @default.
• W4387451353 hasConcept C2776042228 @default.
• W4387451353 hasConcept C2776301714 @default.
• W4387451353 hasConcept C2776780178 @default.
• W4387451353 hasConcept C2776804153 @default.
• W4387451353 hasConcept C2777037409 @default.
• W4387451353 hasConcept C2777714996 @default.
• W4387451353 hasConcept C2779379686 @default.
• W4387451353 hasConcept C2781069245 @default.
• W4387451353 hasConcept C71924100 @default.
• W4387451353 hasConcept C72563966 @default.
• W4387451353 hasConcept C90924648 @default.
• W4387451353 hasConceptScore W4387451353C126322002 @default.
• W4387451353 hasConceptScore W4387451353C142724271 @default.
• W4387451353 hasConceptScore W4387451353C2776042228 @default.
• W4387451353 hasConceptScore W4387451353C2776301714 @default.
• W4387451353 hasConceptScore W4387451353C2776780178 @default.

• next